The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

This segment is sponsored by Eli Lilly and Company.Social media is flooded with advertisments for popular obestiy medications ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...

Racial disparities in childhood obesity have risen due to social determinants, food insecurity, and systemic barriers, ...

For years, people living with obesity have been given the same basic advice: eat less, move more. But while this mantra may ...

More or Less is produced in partnership with the Open University. Presenter: Tim Harford Reporter: Lizzy McNeill Producer: ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.